79 related articles for article (PubMed ID: 11110976)
21. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
22. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
23. Expression of p16 in sporadic primary uveal melanoma.
Lamperska K; Mackiewicz K; Kaczmarek A; Kwiatkowska E; Starzycka M; Romanowska B; Heizman J; Stachura J; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):377-85. PubMed ID: 12362979
[TBL] [Abstract][Full Text] [Related]
24. Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation.
Fombonne J; Devouassoux-Shisheboran M; Bouvier R; Droz JP; Benahmed M; Krantic S
Cancer Detect Prev; 2005; 29(1):1-7. PubMed ID: 15734211
[TBL] [Abstract][Full Text] [Related]
25. [Multiple tumor suppressor 1/p16 gene alterations in human esophageal squamous-cell carcinoma: clinical significance and regional difference].
Lü G; Chen X; Cao W
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):359-62. PubMed ID: 11776574
[TBL] [Abstract][Full Text] [Related]
26. [Alteration of the K-ras and p16/CDKN2 gene in endocrine pancreatic carcinomas].
Shirahama S; Matsuyoshi J; Yamamoto S; Tsukada Y
Nihon Rinsho; 2004 May; 62(5):889-93. PubMed ID: 15148814
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Okai T; Sawabu N
Clin Cancer Res; 1997 Sep; 3(9):1473-7. PubMed ID: 9815833
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
[TBL] [Abstract][Full Text] [Related]
29. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
31. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
32. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
[TBL] [Abstract][Full Text] [Related]
33. Expression of P16 protein and Bcl-2 protein in malignant eyelid tumors.
Niu Y; Zhou Z; Liu F; Wang H
Chin Med J (Engl); 2002 Jan; 115(1):21-5. PubMed ID: 11930651
[TBL] [Abstract][Full Text] [Related]
34. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
[TBL] [Abstract][Full Text] [Related]
36. [Detection of expression of p53, p16, and cyclooxygenase 2 in pancreatic cancer by tissue microarray and correlation among these three genes].
Li YM; Yu ZH; Li L; Xu P; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):939-42. PubMed ID: 16759529
[TBL] [Abstract][Full Text] [Related]
37. [Alterations in DPC4 gene in pancreatic cancers].
Gu L; Chen J; Cui Q
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
[TBL] [Abstract][Full Text] [Related]
38. Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma.
Tiguert R; Bianco FJ; Oskanian P; Li Y; Grignon DJ; Wood DP; Pontes JE; Sarkar FH
J Urol; 2001 Dec; 166(6):2155-60. PubMed ID: 11696726
[TBL] [Abstract][Full Text] [Related]
39. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
40. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands.
Guo XL; Sun SZ; Wang WX; Wei FC; Yu HB; Ma BL
Int J Oral Maxillofac Surg; 2007 Apr; 36(4):350-3. PubMed ID: 17223311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
